Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by mediascan59on Mar 03, 2010 12:50pm
440 Views
Post# 16838653

Tough crowd

Tough crowdWell if it makes any of you  feel any better I am still holding my shares and did get my buy order filled yesterday at .31
That pp was a real kick in the head for us and unfortunately has caused some real damage.
Someone asked where I suspect bottom to be.
I was hoping .27 would hold up but if not, then the gap would be filled at .25
A total collapse of the stock would take us to the Fib line at .235
At this point, charts show we still could go down a bit more but not too much.
So...if .27 cannot hold, I will call .235 and absolute bottom, but suspect .25 is strong enough to hold otherwise.

Mediascan
Bullboard Posts